key: cord-0819220-g1ddzwgs authors: Nie, Xiu; Qian, Liujia; Sun, Rui; Huang, Bo; Dong, Xiaochuan; Xiao, Qi; Zhang, Qiushi; Lu, Tian; Yue, Liang; Chen, Shuo; Li, Xiang; Sun, Yaoting; Li, Lu; Xu, Luang; Li, Yan; Yang, Ming; Xue, Zhangzhi; Liang, Shuang; Ding, Xuan; Yuan, Chunhui; Peng, Li; Liu, Wei; Yi, Xiao; Lyu, Mengge; Xiao, Guixiang; Xu, Xia; Ge, Weigang; He, Jiale; Fan, Jun; Wu, Junhua; Luo, Meng; Chang, Xiaona; Pan, Huaxiong; Cai, Xue; Zhou, Junjie; Yu, Jing; Gao, Huanhuan; Xie, Mingxing; Wang, Sihua; Ruan, Guan; Chen, Hao; Su, Hua; Mei, Heng; Luo, Danju; Zhao, Dashi; Xu, Fei; Zhu, Yi; Xia, Jiahong; Hu, Yu; Guo, Tiannan title: Multi-organ Proteomic Landscape of COVID-19 Autopsies date: 2021-01-09 journal: Cell DOI: 10.1016/j.cell.2021.01.004 sha: 8cd2ce7d289fc3579ea58f57add6d0b0fda32009 doc_id: 819220 cord_uid: g1ddzwgs The molecular pathology of multi-organ injuries in COVID-19 patients remains unclear, preventing effective therapeutics development. Here, we report a proteomic analysis of 144 autopsy samples from seven organs in 19 COVID-19 patients. We quantified 11,394 proteins in these samples, in which 5336 were perturbed in the COVID-19 patients compared to controls. Our data showed that cathepsin L1, rather than ACE2, was significantly upregulated in the lung from the COVID-19 patients. Systemic hyperinflammation and dysregulation of glucose and fatty acid metabolism were detected in multiple organs. We also observed dysregulation of key factors involved in hypoxia, angiogenesis, blood coagulation and fibrosis in multiple organs from the COVID-19 patients. Evidence for testicular injuries include reduced Leydig cells, suppressed cholesterol biosynthesis and sperm mobility. In summary, this study depicts a multi-organ proteomic landscape of COVID-19 autopsies that furthers our understanding of the biological basis of COVID-19 pathology. The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome 59 coronavirus 2 (SARS-CoV-2), has led to more than 55 million infected individuals Table S4 , Figure 1A ). Splenic red pulp samples were excluded from 124 downstream analysis since they did not show any statistically significant proteomic 125 regulations ( Figure 1A ). Hierarchical clustering of the differentially expressed 126 proteins from each organ type ( Figure S3D ) showed that these proteins well separated 127 COVID-19 samples and controls. The t-distributed stochastic neighbor embedding 128 (t-SNE) analysis shows that dysregulated proteomes of each organ type clustered 129 tightly apart from each other ( Figure S3E ), consolidating that these selected proteins 130 well resolved different organ types. Except for testis, other six organ types shared 131 only 27 dysregulated proteins, suggesting different organs responded to viral infection 132 via diverse pathways. Among them, the acute inflammatory protein C-reactive protein 133 (CRP), and the scavenger receptor cysteine-rich type 1 protein M130 (CD163), which 134 is highly expressed marker in M2 type macrophage (Etzerodt and Moestrup, 2013) , 135 were the most upregulated proteins ( Figure 1B ), probably reflecting both the 136 hyperinflammatory and repairing state in patients died from COVID-19. 137 In our study, 14 out of 19 COVID-19 patients exhibited sepsis (Table S1) 149 We then focused on six clusters of proteins including viral receptors and Our data showed substantial regulation of TFs in COVID-19 autopsies. 395 out 162 of 1117 quantified TFs were altered in at least one tissue type (Table S5, Figure S4A ), 163 and they were significantly enriched in spliceosome, viral carcinogenesis, among 164 others as shown in Figure S4B . By matching the experimental fold-change with the 165 predicted activation state in Ingenuity Pathway Analysis (IPA), ten of these 166 dysregulated TFs showed the same regulatory trend. Our data showed that six of these 167 proteins are involved in the inflammatory responses and all of them were upregulated 168 in multiple COVID-19 organs. They are NF-κB subunit 2 (NFKB2) (Lawrence, 2009) , 169 transcription factor p65 (RELA) (Rayet and Gelinas, 1999) , 170 CCAAT/enhancer-binding protein β (C/EBPB) (Greenbaum et al., 1998) suggesting that ACE2 inhibitors might not be an effective therapy for severe and 220 critical COVID-19 patients. However, it was downregulated in both kidney and heart 221 ( Figure 2C ), which may be associated with its modulatory roles on angiotensin II, 222 including inflammation, vasoconstriction and thrombosis (Liu et al., 2020a) . The 223 other two receptors for SARS (Chan et al., 2006; Jeffers et al., 2004) , namely CD209 224 and CLEC4M, were not significantly dysregulated in the lung neither ( Figure 2C ). Interestingly, our results showed CTSL, the serine protease of SARS-CoV-2 in the 226 endosomal pathway, was significantly upregulated in the lung ( Figure 2C ), 227 nominating it as a potential therapeutic target for COVID-19 (Bittmann et al., 2020) . In the SARS-CoV-2 infection cell model, the inhibitor of CTSL has been proven to be (Table S4) . (Table S6 ). In the lung of COVID-19 patients, 236 myeloperoxidase (MPO) for neutrophil primary granules was upregulated (Table S4) , 237 indicating infiltration of neutrophils recruited by IL-1. Interestingly, we also found 238 upregulation of lactate dehydrogenase (LDH) in the lung (Table S4) , which is an 239 indicator of pyroptosis and tissue injuries. Thus, the inhibition of CTSL may also 240 contribute to the excessive inflammatory activity in the COVID-19 patients. Of note, 241 we also observed upregulation of CTSL in the white pulp of spleen, renal medulla, 242 and thyroid ( Figure 2C ). Figure S1 ). VWF is a glycoprotein, which binds to the factor VIII (F8) and 259 protect F8 from degradation by Vitamin K-dependent protein C (PROC). Besides, it 260 could trigger the platelet aggregation following vascular injury (Peyvandi et al., 2011). 261 We found that VWF was increased in the renal cortex in COVID-19 ( Figure 3A (Table S5 , Figure 3B ), suggesting abnormal angiogenesis. Fibrosis has been observed in the lungs of COVID-19 patients ( Figure S1 , Table 280 S1). It is usually divided into four stages, i.e. initiation, inflammation, proliferation 281 and modification (Wynn, 2003) . A cascade of stress and immune responses are (Table S5 ). These Figure S1 ). Nevertheless, our data suggest the fibrosis 297 processes have been triggered in these organs, although microscopically 298 morphological changes were not discernable. These molecular changes might be 299 exploited to instruct tissue fibrosis treatment for the COVID-19 patients. Thrombospondin 1 (THBS1) is an extracellular glycoprotein involved in the 301 inflammation and proliferation stages, and it is highly expressed by stromal 302 fibroblasts and activated platelet (Adams and Lawler, 2011) . Studies have reported its 303 diverse roles in regulating cell-matrix interactions, platelet aggregation, angiogenesis 304 and formation of collagen matrix during wound healing (Bornstein, 2001; Sweetwyne 305 and Murphy-Ullrich, 2012). In the COVID-19 patients, THBS1 was upregulated in 306 the liver, heart and kidney (Table S5) , suggesting potential fibrosis in the COVID-19 307 patients. In the modification stage, multiple lysosomal cathepsins, including CTSL and 309 CTSD, have been reported to play a pro-fibrogenic role in the liver, kidney, heart and (Table S5 ) might contribute to fibrosis in the lung, spleen, thyroid, liver and heart. In addition, we detected 29 fibrosis associated proteins in our dataset according 314 to manual literature mining ( Figure 3C , Table S5 ). SERPINE1 and Chitinase 3 Like 1 315 (CHI3L1) were upregulated in most organs from the COVID-19 patients ( Figure 3C ). Table S6 ). In contrast, fatty acid β oxidation 340 (FAO) and oxidative phosphorylation were activated in most organs, suggesting a 341 switch to high-efficiency energy production mode to support virus replication in the 342 lung and mRNA translation in the liver (Heaton and Randall, 2011 ). In addition, 343 dysregulated FAO and oxidative phosphorylation also led to excessive generation of 344 reactive oxygen species (ROS) and release of proapoptotic proteins, which induced 345 liver necrosis ( Figure S1 ). In the kidney, FAO was inhibited, which is thought to be a 346 contributor to acute kidney injury (AKI) induced renal fibrogenesis (Kang et al., 347 2015). Indeed, AKI has been observed in most COVID-19 patients in our study (Table 348 S1 ). 350 The lung is the major target attacked by SARS-CoV-2. In our data, COVID-19 Immune responses in multiple organs 385 We next investigated the multi-organ immune response in the COVID-19 patients (Table S1 ). In the renal cortex of the COVID-19 428 patients, we detected activation of multiple pathways involving inflammatory 429 response, including the LPS/IL-1 mediated inhibition of RXR function, acute phase 430 response, Toll-like receptor signaling, IL-6 signaling and NF -κB signaling (Table S6) . Of note, Toll-like receptor 2 (TLR2) and its co-receptor CD14, which were reported to The COVID-19 thyroid tissue exhibited lymphoid infiltration (Table S1) (Table S1) , they 495 were histologically healthy as examined by two independent senior pathologists 496 ( Figure S1 ). In addition, future in-depth investigation of the perturbed pathways and 497 the nominated therapeutics is needed. Tables S1 and S2 . 794 We also collected 74 control samples from archived blocks of 56 non-COVID-19 795 patients (Tables S1, S2 ). Control samples in our study were selected from patients (Table 821 S2) were taken for the following TMTpro 16plex labeling based proteomics analysis. The common pooled samples were prepared by mixing equal amount of peptides from 823 six different human organs including testis, lung, kidney, spleen, heart and liver. The Vanstapel Angiogenesis in Covid-19 The thrombospondins Essential role 968 of STAT3 in the control of the acute-phase response as revealed by inducible gene 969 inactivation Hepatocyte nuclear factor 4-alpha involvement in liver 971 and intestinal inflammatory networks The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice The role of the glucocorticoid receptor in 975 inflammation and immunity Autopsy of COVID-19 victims in China Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Proteomics of SARS-CoV-2-infected host cells reveals therapy targets Thrombospondins as matricellular modulators of cell function The Global Phosphorylation 987 Landscape of SARS-CoV-2 Infection How transient becomes stable: an epigenetic switch 989 linking liver inflammation and tumorigenesis Pulmonary post-mortem findings in a series of 992 COVID-19 cases from northern Italy: a two-centre descriptive study Blocking eIF4E-eIF4G interaction as a strategy to impair 995 coronavirus replication Homozygous L-SIGN (CLEC4M) plays a protective role in 998 SARS coronavirus infection SARS-CoV-2 infection protects against 1001 rechallenge in rhesus macaques Fibrinolysis and the control of blood coagulation Small molecule inhibitors reveal Niemann-Pick C1 is essential for 1006 Ebola virus infection Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques RB1: a prototype tumor suppressor and an enigma Hypoxia and inflammation CD163 and inflammation: biological, diagnostic, and 1014 therapeutic aspects Inhibition of lysosomal protease cathepsin D 1017 reduces renal fibrosis in murine chronic kidney disease Accelerated Lysis and Proteolytic Digestion of Biopsy-Level Fresh-Frozen and 1020 FFPE Tissue Samples Using Pressure Cycling Technology Physiological and pathophysiological roles of NAMPT and NAD metabolism PAI-1 in tissue fibrosis The 1026 Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders-A 1027 Systematic Review. Front Immunol 9 A SARS-CoV-2 protein interaction map 1030 reveals targets for drug repurposing CEACAM1: contact-dependent control of 1032 immunity CCAAT enhancer-binding protein beta is required for normal hepatocyte proliferation in mice 1035 after partial hepatectomy Comorbidity and its impact on 1590 patients with 1038 COVID-19 in China: a nationwide analysis A SARS-CoV-2 Infection Model in 1041 Mice Demonstrates Protection by Neutralizing Antibodies Hepatocyte 1043 nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene 1044 expression and lipid homeostasis Heparin 1046 cofactor II inhibits arterial thrombosis after endothelial injury Multifaceted roles for lipids in viral infection AP-1 subunits: quarrel and harmony among siblings The retinoblastoma protein induces apoptosis directly at the 1053 mitochondria Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Sepsis and septic shock The IKK complex, a central regulator of NF-kappaB activation The unique structural and functional features 1063 of CXCL12 is a receptor for severe acute respiratory syndrome coronavirus Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human 1070 Angiotensin-Converting Enzyme 2 Defective fatty acid oxidation in renal tubular epithelial cells has a 1073 key role in kidney fibrosis development Causal analysis 1075 approaches in Ingenuity Pathway Analysis Kidney Biopsy Findings in Patients with COVID-19 The nuclear factor NF-kappaB pathway in inflammation Intracellular sensing of viral genomes and 1082 viral evasion Hypoxia signaling in human diseases 1084 and therapeutic targets TMTpro reagents: 1087 a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements 1088 across 16 samples LSm14A is a processing body-associated sensor of viral nucleic acids that initiates 1091 cellular antiviral response in the early phase of viral infection Nuclear innate sensors for nucleic acids in immunity and inflammation The Science Underlying COVID-19: 1096 Implications for the Cardiovascular System Cathepsin L-selective inhibitors: A potentially 1098 promising treatment for COVID-19 patients PUM1 is a biphasic negative 1100 regulator of innate immunity genes by suppressing LGP2 C-reactive protein levels correlate with mortality and organ failure in critically ill 1104 patients SCIMP is a transmembrane non-TIR TLR 1107 adaptor that promotes proinflammatory cytokine production from macrophages Cathepsin L and B as Potential Markers 1111 for Liver Fibrosis: Insights From Patients and Experimental Models Extraribosomal l13a is a specific innate immune factor for antiviral defense Severe hypoxia specifically 1117 downregulates hepatocyte nuclear factor-4 gene expression in HepG2 human hepatoma cells RNF216 is essential for spermatogenesis and male fertilitydagger Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis 1128 via TGF-beta1-dependent and -independent mechanisms Nexin-Dynein regulatory complex component DRC7 but not 1131 FBXL13 is required for sperm flagellum formation and male fertility in mice Factor XIII: a 1134 coagulation factor with multiple plasmatic and cellular functions Vascular 1136 permeability, vascular hyperpermeability and angiogenesis Translation: Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7) The Role of TLR2 in Infection 1141 and Immunity Multiple Cathepsins Promote Pro-IL-1beta Synthesis and NLRP3-Mediated IL-1beta Activation Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune 1147 cross-reactivity with SARS-CoV Overview of the coagulation system Sepsis associated acute kidney injury Aberrant rel/nfkb genes and activity in human cancer RIG-I-like receptors: their regulation and roles in RNA 1154 sensing Signaling Pathways Involved in the Regulation of mRNA 1156 Translation Interferon-gamma: an 1158 overview of signals, mechanisms and functions Cytoscape: a software environment for integrated 1161 models of biomolecular interaction networks Comparative analysis of mRNA and protein degradation in prostate 1164 tissues indicates high stability of proteins Proteomic and Metabolomic Characterization of COVID-19 Patient Sera Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. medRxiv Renal histopathological analysis of 26 postmortem findings of patients with 1173 COVID-19 in China Renal histopathological analysis of 26 postmortem findings of patients with 1176 COVID-19 in China Thrombospondin1 in tissue repair and 1178 fibrosis: TGF-beta-dependent and independent mechanisms STRING v11: protein-protein association 1181 networks with increased coverage, supporting functional discovery in genome-wide experimental datasets Severe acute 1184 respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a 1185 specific translational shutoff of host mRNA Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 1188 5'TOP mRNA translation Pathological study 1190 of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod 1191 Pathol The N-terminal domain of the 1193 murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the 1194 virus strain Proteomics. Tissue-based 1197 map of the human proteome Autopsy Findings and 1200 Venous Thromboembolism in Patients With COVID-19 Viral product trafficking to 1202 mitochondria, mechanisms and roles in pathogenesis IL-13 effector functions Viral dedication to vigorous destruction of 1208 interferon receptors Pathological Findings in the Testes of COVID-19 Patients: Clinical 1215 pH-dependent entry of severe acute respiratory syndrome coronavirus is 1218 mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN Inflammasomes and Pyroptosis as 1224 Therapeutic Targets for COVID-19 STATs in cancer inflammation and immunity: a leading role for STAT3 Testicular defense systems: immune privilege 1228 and innate immunity Chitinase-3 like-protein-1 function and 1230 its role in diseases Metascape provides a biologist-oriented resource for the analysis of 1233 systems-level datasets High-throughput proteomic analysis of FFPE tissue samples facilitates tumor 1236 stratification